| ScinoPharm Taiwan Ltd. Patent applications |
| Patent application number | Title | Published |
|---|
| 20120107941 | REAL-TIME MONITOR SOLID PHASE PEPTIDE SYNTHESIS BY MASS SPECTROMETRY - Provided are systems, apparatus, materials and methods for directly monitoring products and intermediates of solid phase chemical synthesis such as solid phase peptide synthesis. | 05-03-2012 |
| 20110288235 | Process for the Preparation of Pramlintide - The present invention provides for an efficient process for making pramlinitide, as well as novel intermediates for the making of the same. | 11-24-2011 |
| 20110287550 | Method for continuously monitoring solution-phase synthesis of oligonucleotide - The present invention provides a system and method for real-time continuously monitoring of oligonucleotide synthesis in solution phase. | 11-24-2011 |
| 20110183426 | Methods for Chemical Equivalence in Characterizing of Complex Molecules - The present invention provides for a method of characterizing and classifying a sample containing a complex molecule, such as a peptide or polypeptide mixture, protein, protein mixture, biologic and biosimilar by using physical analysis, such as mass spectrometry, and statistic methods. | 07-28-2011 |
| 20110124509 | Inhibition-Based High-Throughput Screen Strategy for Cell Clones - A method for screening cells with high level expression of a target protein is disclosed. The method includes introducing into a plurality of host cells a DNA construct that encodes both a target protein and an inhibitor to an endogenous selectable marker in the host cells, screening host cells harboring the DNA construct for the expression of the endogenous selectable marker, and isolating cells with reduced expression of the selectable marker. Also disclosed is a DNA construct configured to express both the target protein and the inhibitor inside the host cell. | 05-26-2011 |
| 20110065750 | Solid Forms of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione and Methods of Making the Same - The present invention provides for new crystalline and amorphous forms of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione, and methods of making the same. | 03-17-2011 |
| 20100317532 | INHIBITION-BASED HIGH-THROUGHPUT SCREEN STRATEGY FOR CELL CLONES - A method for screening cells with high level expression of a target protein is disclosed. The method includes introducing into a plurality of host cells a DNA construct that encodes both a target protein and an inhibitor to an endogenous selectable marker in the host cells, screening host cells harboring the DNA construct for the expression of the endogenous selectable marker, and isolating cells with reduced expression of the selectable marker. Also disclosed is a DNA construct configured to express both the target protein and the inhibitor inside the host cell. | 12-16-2010 |
| 20100285513 | Methods of Analyzing Peptide Mixtures - The present invention provides for a method of characterizing and classifying a sample of peptide or polypeptide mixtures or a biomolecule comprising a polypeptide component by using mass spectrometry and statistic methods for analyzing the mass spectrometry results. | 11-11-2010 |
| 20100081788 | Process for the Preparation of Pramlintide - The present invention provides for an efficient process for making Pramlinitide, as well as novel intermediates for the making of the same. | 04-01-2010 |
| 20100056771 | Process of Making 2-Deoxy-2,2-Difluoro-D-Ribofuranosyl Nucleosides and Intermediates Therefor - A compound of formula (A) or salt thereof: | 03-04-2010 |
| 20090221826 | Process for making topotecan - A process of making topotecan or a pharmaceutically acceptable salt thereof comprising reacting an iminium salt with 10-hydroxy-camptothecin. | 09-03-2009 |
| 20090076283 | Method of crystallizing carvedilol phosphate and the product thereof - The present invention provides for a crystalline polymorph of Carvedilol phosphate salt and a process for making the same. | 03-19-2009 |
| 20090069584 | Levonorgestrel Crystallization - The present invention provides for a crystalline polymorph of levonorgestrel and processes for making the same. | 03-12-2009 |
| 20090035816 | Process for the preparation of a polypeptide - A process for the preparation of a polypeptide made from amino acids L-alanine, L-glutamic acid, L-lysine, and L-tyrosine comprising using N-thiocarboxyanhydride of at least one amino acid as a starting material. | 02-05-2009 |
| 20090018356 | Crystalline polymorph of exemestane - New crystalline polymorph of exemestane characterized by a powder X-ray diffraction pattern having peaks at 10.7±0.1, 15.9±0.1, and 18.1±0.1 2-theta degree. | 01-15-2009 |
| 20090012111 | Crystalline polymorph of 7-ethyl-10-hydroxycamptothecin - A crystalline polymorph of 7-ethyl-10-hydroxycamptothecin exhibiting an X-ray diffraction pattern having peaks at 10.9±0.2, 13.2±0.2, 23.9±0.2, and 26.1±0.2 2-theta degree. | 01-08-2009 |
| 20080275259 | Process for preparing aromatase inhibitors - A process of making an aromatase inhibitor of formula (I) | 11-06-2008 |
| 20080269493 | Crystalline forms of topotecan hydrochloride and processes for making the same - Novel crystalline forms of topotecan hydrochloride and processes of making the same are disclosed. | 10-30-2008 |
